Sanara MedTech annual r&d spending
2020
2021
2022
2023
2024
2025
Sanara MedTech R&D Spending Growth & History (SMTI)
Sanara MedTech's r&d spending was $5.1M for fiscal 2025.
View full Sanara MedTech company overviewSanara MedTech annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.1M | $2.2M | +79.32% |
| 2024 | 2024-12-31 | $2.8M | −$1.3M | −31.55% |
| 2023 | 2023-12-31 | $4.1M | $765,393 | +22.73% |
| 2022 | 2022-12-31 | $3.4M | $2.8M | +502.65% |
| 2021 | 2021-12-31 | $558,704 | $518,514 | +1290.16% |
| 2020 | 2020-12-31 | $40,190 | — | — |
Sanara MedTech quarterly r&d spending
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.2M | $97,436 | +9.22% |
| Q1 2026 | 2026-03-31 | $759,592 | −$190,767 | −20.07% |
| Q4 2025 | 2025-12-31 | $2.0M | $1.9M | +1703.55% |
| Q3 2025 | 2025-09-30 | $1.0M | $245,751 | +31.35% |
| Q2 2025 | 2025-06-30 | $1.1M | $71,145 | +7.22% |
| Q1 2025 | 2025-03-31 | $950,359 | $4,061 | +0.43% |
| Q4 2024 | 2024-12-31 | $112,874 | −$538,645 | −82.68% |
| Q3 2024 | 2024-09-30 | $783,840 | −$202,614 | −20.54% |
| Q2 2024 | 2024-06-30 | $985,651 | −$191,477 | −16.27% |
| Q1 2024 | 2024-03-31 | $946,298 | −$371,026 | −28.17% |
| Q4 2023 | 2023-12-31 | $651,519 | −$382,489 | −36.99% |
| Q3 2023 | 2023-09-30 | $986,454 | −$74,933 | −7.06% |
| Q2 2023 | 2023-06-30 | $1.2M | $110,128 | +10.32% |
| Q1 2023 | 2023-03-31 | $1.3M | $1.1M | +543.74% |
| Q4 2022 | 2022-12-31 | $1.0M | $733,171 | +243.71% |
| Q3 2022 | 2022-09-30 | $1.1M | $1.0M | +2875.24% |
| Q2 2022 | 2022-06-30 | $1.1M | $963,019 | +926.15% |
| Q1 2022 | 2022-03-31 | $204,637 | $86,425 | +73.11% |
| Q4 2021 | 2021-12-31 | $300,837 | — | — |
| Q3 2021 | 2021-09-30 | $35,674 | $24,652 | +223.66% |
| Q2 2021 | 2021-06-30 | $103,981 | $62,465 | +150.46% |
| Q1 2021 | 2021-03-31 | $118,212 | $113,825 | +2594.60% |
| Q3 2020 | 2020-09-30 | $11,022 | — | — |
| Q2 2020 | 2020-06-30 | $41,516 | — | — |
| Q1 2020 | 2020-03-31 | $4,387 | — | — |
Sanara MedTech r&d spending trends
Over the last five fiscal years, Sanara MedTech's r&d spending increased from $40,190 to $5.1M, a change of $5.0M. The latest reported quarter, Q2 2026, shows $1.2M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sanara MedTech source filings ↗